Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's p... Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. Show more
ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured by MRI-PDFFPlacebo-adjusted median relative reductions in liver fat...
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving...
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving...
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on developing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.165 | -28.9638386648 | 14.38 | 16.24 | 10.18 | 52363 | 14.24833632 | CS |
4 | -3.575 | -25.9245830312 | 13.79 | 19.5 | 10.18 | 74718 | 15.62029761 | CS |
12 | 0.335 | 3.39068825911 | 9.88 | 19.5 | 8.75 | 331506 | 12.17077545 | CS |
26 | -12.535 | -55.0989010989 | 22.75 | 27.5 | 8.75 | 313723 | 15.46926447 | CS |
52 | -9.785 | -48.925 | 20 | 30 | 8.75 | 303353 | 16.98754834 | CS |
156 | -382.535 | -97.3991088479 | 392.75 | 449.25 | 8.75 | 267335 | 56.87278725 | CS |
260 | -358.285 | -97.2279511533 | 368.5 | 937.7475 | 8.75 | 246092 | 133.17845912 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.